ABA Will Back Myriad's Gene Patents In Supreme Court
The American Bar Association voted Monday to back Myriad Genetics Inc.'s bid to retain patents for isolated breast cancer genes and to oppose a Federal Circuit ruling that lowered the bar...To view the full article, register now.
Already a subscriber? Click here to view full article